Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2020/03/023757
CTRI/2020/03/023757OtherPhase 3

USG guided brachial plexus block: A comparison of analgesia duration using Bupivacaine with and without Dexamethasone as adjuvant.

IAF1 site in 1 country32 target enrollmentStarted: September 3, 2020Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 3
Status
Other
Sponsor
IAF
Enrollment
32
Locations
1
Primary Endpoint
Compare the duration of Analgesia of brachial plexus block and time to first additional analgesic
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Brachial plexus block is one of the preferred techniques for anaesthesia for upper limb surgeries. The advantage being that of analgesia lasting even after the anaesthesia with motor block wears off. Many adjuvants have been explored for co-administration along with the local anaesthetic to prolong this period. Each of these adjuvants has its own side effect profile, with this study we will attempt at understanding the analgesic effect and duration and also the side effect profile by comparing blood sugar levels and duration of motor blockade.

Study Design

Study Type
Interventional
Allocation
Other
Masking
Participant, Investigator and Outcome Assessor Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Posted for Open Reduction Internal Fixation of UpperLimb fractures
  • •Upper limb surgery where Supraclavicular brachial plexus block is indicated.

Exclusion Criteria

  • •Weight less than 40 Kg
  • •Pregnancy
  • •Poor sensorium (GCS < 13)
  • •Contraindications to Dexamethasone
  • •Diabetes Mellitus
  • •Patients on current steroid therapy or within past 6 weeks.

Outcomes

Primary Outcomes

Compare the duration of Analgesia of brachial plexus block and time to first additional analgesic

Time Frame: Measured over 48 hours

Secondary Outcomes

  • Duration of motor weakness of arm measured every 6 hours(Measured over 48 hours)
  • Postoperative blood sugar every 6 hours(Measured over 48 hours)

Investigators

Sponsor
IAF
Sponsor Class
Other [Government Hospital]

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Not Applicable
Parasagittal Vs Cornerpocket ApproachesSupraclavicular Brachial Plexus Block
NCT06352333Sohag University80
Completed
Not Applicable
Comparison of Ultrasound-guided Brachial Plexus Blocks and Selective Distal Blocks in Terms of AnesthesiaPain, PostoperativeAnesthesia, LocalPatient Satisfaction
NCT05656625Samsun University2
Unknown
Not Applicable
Prospective Clinical Trial Comparing Infraclavicular Versus Axillary Approach to Brachial Plexus BlockScaphoid FracturesDistal Radius FracturesWrist Injury Arthrodesis
NCT02208245Federal University of São Paulo46
Unknown
Phase 4
Comparison of Infraclavicular And Supraclavicular BlockAnesthesia ConductionUpper Extremity SurgeryPain, PostoperativeAnesthesia and AnalgesiaNerve BlockBrachial Plexus Block
NCT04784104Bozyaka Training and Research Hospital70
Completed
Not Applicable
Comparison of Supraclavicular and Costoclavicular Brachial Plexus Blocks in PediatricsAnesthesia, LocalPostoperative Pain
NCT04782778Istanbul University58